European policymakers are about to confront a long-standing taboo over giving plasma, the liquid part of blood, for money.
- Sarah-Taïssir Bencharif
It’s a pressing question:
The European Union is short of the plasma needed to make life-saving medicines.
It depends on imports — mostly from paid donors in the U.S. — to meet the needs of around 300,000 people who require plasma-derived medicinal products (PDMPs).
Advocates on both sides of the…